CONFERENCE COVERAGE SERIES
Northeast ALS Consortium 2011
Fort Lauderdale, Florida, U.S.A.
26 October 2011
Starting on October 26, 2011, clinicians and some people with amyotrophic lateral sclerosis (ALS) gathered for an unusual conference in Fort Lauderdale, Florida. They are the Northeast ALS Consortium, or NEALS, which has grown to be a U.S.-Canadian-European powerhouse in ALS clinical trials. The collaborative has tested varied trial designs, hunted for biomarkers to make those trials work better, and consistently shared data and resources to boost ALS research, and has begun to expand its patient outreach with projects such as an educational retreat at the meeting.
NEALS: Collaboration for a Cure to ALS
In the field of amyotrophic lateral sclerosis (ALS), the Northeast ALS Consortium (NEALS) is the hands-down largest and hardest-working township in North America...
NEALS: In ALS Trials, One Design Does Not Fit All
Since 1995, NEALS has united clinicians around the common goal of bringing potential medicines to people by mounting large, multicenter clinical trials...
NEALS: Desperately Seeking ALS Biomarkers
Researchers studying amyotrophic lateral sclerosis (ALS) have plenty of drug ideas to try, but a great problem in figuring out if they work or not...
NEALS: Sharing Among ALS Researchers and Participants
Willing participants—particularly with a rare disease such as ALS—are scattered so sparsely across the country that any one clinic cannot hope to recruit sufficient numbers...